ShockWave Medical, Inc.
SWAV · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $730 | $490 | $237 | $68 |
| % Growth | 49.1% | 106.5% | 249.8% | – |
| Cost of Goods Sold | $95 | $65 | $41 | $21 |
| Gross Profit | $635 | $425 | $196 | $47 |
| % Margin | 86.9% | 86.7% | 82.5% | 69% |
| R&D Expenses | $146 | $82 | $51 | $37 |
| G&A Expenses | $95 | $57 | $35 | $24 |
| SG&A Expenses | $330 | $219 | $146 | $76 |
| Sales & Mktg Exp. | $235 | $162 | $111 | $52 |
| Other Operating Expenses | $24 | $1 | -$1 | $0 |
| Operating Expenses | $469 | $301 | $197 | $112 |
| Operating Income | $166 | $124 | -$1 | -$66 |
| % Margin | 22.7% | 25.3% | -0.4% | -96.9% |
| Other Income/Exp. Net | $8 | -$3 | -$8 | $0 |
| Pre-Tax Income | $174 | $121 | -$9 | -$66 |
| Tax Expense | $27 | -$95 | $0 | $0 |
| Net Income | $147 | $216 | -$9 | -$66 |
| % Margin | 20.2% | 44.1% | -3.9% | -96.9% |
| EPS | 4.01 | 6.02 | -0.26 | -1.99 |
| % Growth | -33.4% | 2,415.4% | 86.9% | – |
| EPS Diluted | 3.85 | 5.7 | -0.26 | -1.99 |
| Weighted Avg Shares Out | 37 | 36 | 35 | 33 |
| Weighted Avg Shares Out Dil | 38 | 38 | 35 | 33 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $2 | $1 | $1 |
| Interest Expense | $6 | $2 | $1 | $1 |
| Depreciation & Amortization | $10 | -$1 | -$7 | $1 |
| EBITDA | $191 | $128 | -$1 | -$63 |
| % Margin | 26.1% | 26% | -0.4% | -93.2% |